Publicaciones científicas
De novo variants in immune regulatory genes in Down syndrome regression disorder
Saba Jafarpour 1 2 , Abhik K Banerjee 1 , Mellad M Khoshnood 1 2 3 , Benjamin N Vogel 1 , Natalie K Boyd 1 , Lina Nguyen 1 , Rebecca Partridge 4 , Stephanie L Santoro 5 6 , Grace Y Gombolay 7 , Kristen S Fisher 8 , Diego Real de Asua 9 , Maria Carmen Del Ortega 10 , Cathy Franklin 11 , Michael S Rafii 2 , Jonathan D Santoro 12 13
Background: Down Syndrome Regression Disorder (DSRD) is a rare and poorly understood disorder of the central nervous system, characterized by acute or subacute neuropsychiatric symptoms in previously healthy individuals with Down syndrome (DS). Many patients exhibit immunotherapy-responsiveness, indicative of immune dysregulation as a potential underlying etiology. While hypotheses are emerging regarding the role of interferon signaling in DSRD and other autoimmune conditions associated with DS, it is unclear why a small subset of individuals with DS develop DSRD. The aim of this study was to investigate genes of immune regulation in persons with DSRD.
Methods: This study included individuals with DSRD aged 10-30 years with trio exome sequencing performed during the diagnostic work up. Descriptive statistics and univariate analysis (Chi-square and Fisher's exact test) were used to describe and compare the characteristics of individuals with and without variants.
Results: Forty-one individuals with DSRD had trio exome sequencing results. Eight (20%) had heterozygous de novo variants of immune regulatory genes, with four variants being pathogenic or likely pathogenic (UNC13D, XIAP, RNASEH2A, and DNASE1L3). All genes harboring pathogenic variants were associated with interferon type-1 inflammatory response. Individuals harboring variants were more likely to have a preceding trigger (p = 0.03, 95% CI 1.21-97.06), rapid clinical decline in less than 1 month (p = 0.01, 95% CI 1.67-52.06), and MRI abnormalities (p < 0.001, 95% CI 4.89-527.71).
Discussion: A distinct subset of individuals with DSRD exhibited pathogenic variants in immune regulation genes associated with interferon-mediated inflammatory response, coinciding with previously established links between these genes and interferonopathies such as Aicardi-Goutieres syndrome. Our observations suggest that these variants might potentially contribute to the development of DSRD in individuals with DS.
CITA DEL ARTÍCULO J. Neurol. 2024 Jun 22. doi: 10.1007/s00415-024-12521-y
Nuestros autores
